| Timing of the conference for Tuesday, 2nd September 2008 and for Wednesday, 3rd September 2008 |
|
Tuesday, 2nd September 2008
|
| 08.00 am |
Coffee & Registration |
| 08.30 am |
Welcome & Opening
Jörg Freimund, Managing Director, Sal. Oppenheim jr. & Cie. KGaA |
| 08.35 am |
Opening Presentation
"Trends in the Global Healthcare Market"
Peter Düllmann, Senior Vice President,
Oppenheim Research GmbH |
| Company Presentations |
| 08.50 am |
Heidelberg Pharma AG
Dr. Marcel Linssen,
SVP Corporate Development & Marketing |
| 09.10 am |
F. Hoffmann-La Roche Ltd
Dr. Karl Mahler, Head of IR |
| 09.40 am |
Qiagen N.V.
Dr. Joachim Schorr, Managing Director and SVP Global R&D
Solveigh Mähler, Director IR |
| 10.00 am |
Merck KGaA
Dr. Monika Buttkereit, Manager IR; Dr. Thomas Kornek, Manager IR |
| 10.30 am |
Gerresheimer AG
Hans-Jürgen Wiecha, CFO |
| 10.50 am |
Coffee Break |
| 11.30 am |
Wilex AG
Prof. Dr. Olaf Wilhelm, CEO |
| 11.50 am |
Arpida AG
Harry Welten, CFO |
| 12.10 pm |
Intercell AG
Dr. Gerd Zettlmeissl, CEO |
| 12.30 pm |
Evotec AG
Jörn Aldag, CEO |
| 12.50 pm |
Lunch |
| 02.00 pm |
Coltene Holding AG
Andreas Meldau, CEO
Dr. Hans Grüter, CFO |
| 02.20 pm |
Straumann Holding AG
Fabian Hildbrand, Head of IR |
| 02.40 pm |
Celesio AG
Torben Bonnke, Corporate IR Manager |
| 03.10 pm |
Sonova Holding AG
Oliver Walker, CFO |
| 03.30 pm |
Synthes, Inc.
Gilgian Eisner, Head IR |
| 03.50 pm |
Coffee Break |
| 04.20 pm |
Nobel BioCare Holding AG
Dr. Dirk Kirsten, CFO |
| 04.40 pm |
Basilea Pharmaceutica AG
Ron Scott, CFO |
| 05.00 pm |
Biotest AG
Prof. Dr. Gregor Schulz, CEO
Dr. Michael Ramroth, CFO |
| 05.20 pm |
4SC AG
Dr. Ulrich Dauer, CEO
|
| 06.00 pm |
Cocktail Break |
| 07.00 pm |
Dinner |
| 08.00 pm |
Keynote Speech
Prof. Dr. Dr. h.c. Rolf Krebs former Chairman of
the Board of Managing Directors at Boehringer Ingelheim |
| 08.30 pm |
Get together |
Wednesday, 3rd September 2008
|
| 08.30 am |
Coffee & Registration |
| Company Presentations |
| 09.00 am |
Actelion Pharmaceuticals Ltd.
Roland Haefeli, VP Investor Relations & Public Affairs |
| 09.20 am |
Novo Nordisk A/S
Lars Green, Senior Vice President of Corporate Finance Management
|
| 09.50 am |
Alapis S.A.
John Papavasiliou, CFO |
| 10.10 am |
Cosmo Pharmaceuticals SpA
Dr. Chris Tanner, CFO |
| 10.30 am |
Drägerwerk AG & Co. KGaA
Gert-Hartwig Lescow, CFO
Vanina Herbst, IR |
| 10.50 am |
Coffee Break |
| 11.20 am |
AmVac AG
Dr. Wolfgang Schmidt, COO
Dr. Tilman Dumrese, CFO |
| 11.40 am |
Rhön-Klinikum AG
Dietmar Pawlik, CFO |
| 12.00 pm |
Medigene AG
Dr. Thomas Klaue, CFO |
| 12.20 pm |
Morphosys AG
Dr. Simon E. Moroney, CEO |
| 12.40 pm |
Lunch |
| 01.50 pm |
Newron Pharmaceuticals SpA
Dr. Luca Benatti, CEO |
| 02.10 pm |
Paion AG
Dr. Wolfgang Söhngen, CEO |
| 02.30 pm |
Sygnis AG
Dr. Alfred Bach, CEO
Peter Willinger, CFO |
| 02.50 pm |
Cytos Biotechnology AG
Dr. Wolfgang Renner,
CEO & Delegate of the Board of Directors |
| 03.10 pm |
Curanum AG
Hans-Milo Halhuber, CEO
|
| 03.30 pm |
Closing remarks
Dr. Jan zur Hausen, Senior Vice President, Healthcare Investment Banking, Sal. Oppenheim jr. & Cie. KGaA |
